IL241065A0 - Fatty compositions of rascadotril - Google Patents
Fatty compositions of rascadotrilInfo
- Publication number
- IL241065A0 IL241065A0 IL241065A IL24106515A IL241065A0 IL 241065 A0 IL241065 A0 IL 241065A0 IL 241065 A IL241065 A IL 241065A IL 24106515 A IL24106515 A IL 24106515A IL 241065 A0 IL241065 A0 IL 241065A0
- Authority
- IL
- Israel
- Prior art keywords
- lipid compositions
- racecadotril lipid
- racecadotril
- compositions
- lipid
- Prior art date
Links
- -1 Racecadotril lipid Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960002281 racecadotril Drugs 0.000 title 1
- 108700040249 racecadotril Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- General Preparation And Processing Of Foods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361787597P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/023903 WO2014150660A1 (en) | 2013-03-15 | 2014-03-12 | Racecadotril lipid compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL241065A0 true IL241065A0 (en) | 2015-11-30 |
Family
ID=50628914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL241065A IL241065A0 (en) | 2013-03-15 | 2015-09-02 | Fatty compositions of rascadotril |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9801819B2 (enExample) |
| EP (1) | EP2968138B1 (enExample) |
| JP (1) | JP2016512828A (enExample) |
| KR (1) | KR20160101167A (enExample) |
| CN (1) | CN105246460A (enExample) |
| AU (2) | AU2014235733B2 (enExample) |
| BR (1) | BR112015023387A2 (enExample) |
| CA (2) | CA2907195A1 (enExample) |
| IL (1) | IL241065A0 (enExample) |
| MX (2) | MX2015012345A (enExample) |
| PH (1) | PH12015502014A1 (enExample) |
| RU (2) | RU2662069C2 (enExample) |
| SA (1) | SA515361092B1 (enExample) |
| WO (2) | WO2014150660A1 (enExample) |
| ZA (1) | ZA201507661B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9084721B2 (en) | 2012-06-28 | 2015-07-21 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| US9801819B2 (en) | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| KR20150023876A (ko) | 2012-06-28 | 2015-03-05 | 맥네일-피피씨, 인코포레이티드 | 라세카도트릴 지질 조성물 |
| US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| CN105848643A (zh) * | 2013-12-23 | 2016-08-10 | 强生消费者公司 | 消旋卡多曲组合物 |
| EP3331520A1 (en) * | 2015-08-07 | 2018-06-13 | Johnson & Johnson Consumer Inc. | Methods of treatment using cadotril compositions |
| EP3503926B1 (en) * | 2016-08-23 | 2023-06-07 | Johnson & Johnson Consumer Inc. | New improved composition of racecadotril |
| KR102771577B1 (ko) | 2017-11-27 | 2025-02-20 | 유메크린 코그니션 에이비 | 3α-에티닐-3β-하이드록시안드로스탄-17-온 옥심의 약학적 제형 |
| US20210378970A1 (en) * | 2018-02-26 | 2021-12-09 | R.P. Scherer Technologies, Llc | Pharmaceutical dosage form for an emulsion of simethicone and loperamide |
| KR102676428B1 (ko) * | 2019-07-08 | 2024-06-19 | 가부시키가이샤 모레스코 | 마이크로에멀션을 조제하기 위한 조성물, 마이크로에멀션, 이들의 제조 방법, 및 마이크로에멀션의 이용 |
| US20230398102A1 (en) * | 2020-10-29 | 2023-12-14 | Bausch Health Ireland Limited | Rifaximin liquid formulations for use inthe treatment of sickle cell disease |
| WO2025212856A1 (en) * | 2024-04-05 | 2025-10-09 | The Board Of Regents Of The University Of Texas System | Microemulsion formulations |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2480747A1 (fr) | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
| FR2623498B1 (fr) | 1987-11-24 | 1990-04-06 | Bioprojet Soc Civ | Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques |
| US5136076A (en) | 1987-11-24 | 1992-08-04 | Societe Civile Bioprojet | Process for the preparation of amino acid-derived enatiomeric compounds |
| SE9503143D0 (sv) * | 1995-09-12 | 1995-09-12 | Astra Ab | New preparation |
| EP0914822A4 (en) | 1996-03-14 | 2002-08-07 | Bayer Ag | PREPARATION OF ECADOTRIL WITH FAST MICRODISPERSION AND RELEASE |
| WO1998040051A1 (en) | 1997-03-12 | 1998-09-17 | Abbott Laboratories | Lipophilic binary systems for the administration of lipophilic compounds |
| GB9907715D0 (en) | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
| DE60112756T2 (de) | 2000-06-23 | 2006-06-08 | Bioprojet | Racecadotril enthaltende trockene pulverformulierung |
| GB0015490D0 (en) | 2000-06-23 | 2000-08-16 | Smithkline Beecham Lab | Novel formulations |
| EP1563848A1 (en) | 2004-02-12 | 2005-08-17 | Bioprojet | New combinations of an anti-emetic agent and an enkephalinase inhibitor |
| FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| CN101103960B (zh) | 2006-07-14 | 2010-12-08 | 海南盛科生命科学研究院 | 一种含有消旋卡多曲的干混悬剂及其制备方法 |
| CN101264065A (zh) | 2008-04-18 | 2008-09-17 | 盐城苏海制药有限公司 | 消旋卡多曲滴丸及其制备方法 |
| RU2012102772A (ru) | 2009-06-29 | 2013-08-10 | МакНЕЙЛ-ППС, ИНК. | Фармацевтическая таблетка, содержащая заполненную жидкостью капсулу |
| CN102018707A (zh) * | 2010-11-29 | 2011-04-20 | 昆明邦宇制药有限公司 | 一种治疗腹泻的药物组合物及其制剂 |
| EP2462922A1 (en) | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
| CN102133186B (zh) | 2011-03-18 | 2012-08-01 | 海南美大制药有限公司 | 一种消旋卡多曲脂质体固体制剂 |
| CN102327234B (zh) | 2011-09-28 | 2017-04-12 | 海南康芝药业股份有限公司 | 一种消旋卡多曲干混悬剂 |
| US9801819B2 (en) | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| US9114171B2 (en) | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| KR20150023876A (ko) * | 2012-06-28 | 2015-03-05 | 맥네일-피피씨, 인코포레이티드 | 라세카도트릴 지질 조성물 |
| US9084721B2 (en) | 2012-06-28 | 2015-07-21 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| TR201801726T4 (tr) | 2012-12-26 | 2018-03-21 | Ilko Ilac Sanayi Veticaret A S | Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇. |
| EP3331520A1 (en) | 2015-08-07 | 2018-06-13 | Johnson & Johnson Consumer Inc. | Methods of treatment using cadotril compositions |
-
2013
- 2013-12-23 US US14/138,309 patent/US9801819B2/en active Active
-
2014
- 2014-03-12 BR BR112015023387A patent/BR112015023387A2/pt not_active Application Discontinuation
- 2014-03-12 AU AU2014235733A patent/AU2014235733B2/en not_active Expired - Fee Related
- 2014-03-12 JP JP2016501378A patent/JP2016512828A/ja active Pending
- 2014-03-12 EP EP14720750.0A patent/EP2968138B1/en active Active
- 2014-03-12 US US14/205,565 patent/US9636300B2/en active Active
- 2014-03-12 CN CN201480015975.XA patent/CN105246460A/zh active Pending
- 2014-03-12 MX MX2015012345A patent/MX2015012345A/es unknown
- 2014-03-12 WO PCT/US2014/023903 patent/WO2014150660A1/en not_active Ceased
- 2014-03-12 CA CA2907195A patent/CA2907195A1/en not_active Abandoned
- 2014-03-12 RU RU2015144013A patent/RU2662069C2/ru not_active IP Right Cessation
- 2014-12-22 RU RU2016129907A patent/RU2016129907A/ru not_active Application Discontinuation
- 2014-12-22 MX MX2016008390A patent/MX2016008390A/es unknown
- 2014-12-22 AU AU2014370027A patent/AU2014370027A1/en not_active Abandoned
- 2014-12-22 KR KR1020167019811A patent/KR20160101167A/ko not_active Withdrawn
- 2014-12-22 WO PCT/US2014/071887 patent/WO2015100234A1/en not_active Ceased
- 2014-12-22 CA CA2934816A patent/CA2934816A1/en not_active Abandoned
-
2015
- 2015-09-02 IL IL241065A patent/IL241065A0/en unknown
- 2015-09-09 PH PH12015502014A patent/PH12015502014A1/en unknown
- 2015-09-14 SA SA515361092A patent/SA515361092B1/ar unknown
- 2015-10-14 ZA ZA2015/07661A patent/ZA201507661B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014370027A1 (en) | 2016-07-07 |
| WO2014150660A1 (en) | 2014-09-25 |
| KR20160101167A (ko) | 2016-08-24 |
| PH12015502014A1 (en) | 2016-01-11 |
| JP2016512828A (ja) | 2016-05-09 |
| RU2016129907A3 (enExample) | 2018-09-13 |
| MX2016008390A (es) | 2017-01-11 |
| CA2907195A1 (en) | 2014-09-25 |
| EP2968138B1 (en) | 2018-08-15 |
| BR112015023387A2 (pt) | 2017-07-18 |
| RU2015144013A (ru) | 2017-04-28 |
| RU2662069C2 (ru) | 2018-07-23 |
| US20140275246A1 (en) | 2014-09-18 |
| AU2014235733B2 (en) | 2018-11-01 |
| US9636300B2 (en) | 2017-05-02 |
| RU2016129907A (ru) | 2018-01-30 |
| US20160331684A9 (en) | 2016-11-17 |
| EP2968138A1 (en) | 2016-01-20 |
| US9801819B2 (en) | 2017-10-31 |
| CN105246460A (zh) | 2016-01-13 |
| SA515361092B1 (ar) | 2018-01-17 |
| AU2014235733A1 (en) | 2015-09-24 |
| MX2015012345A (es) | 2017-03-27 |
| CA2934816A1 (en) | 2015-07-02 |
| ZA201507661B (en) | 2017-09-27 |
| WO2015100234A1 (en) | 2015-07-02 |
| US20140271832A1 (en) | 2014-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288961A (en) | Pharmaceutical preparations | |
| HUE041452T2 (hu) | Új lipid | |
| GB201304662D0 (en) | Compositions | |
| GB201319791D0 (en) | Formulations | |
| SG11201602596UA (en) | Stabilized efinaconazole compositions | |
| PL2943181T3 (pl) | Kompozycje farmaceutyczne | |
| IL243434A0 (en) | Oral preparations | |
| ZA201507661B (en) | Racecadotril lipid compositions | |
| ZA201408333B (en) | Pharmaceutical compositions | |
| GB201608461D0 (en) | Compositions | |
| GB201319792D0 (en) | Formulations | |
| GB2511350B (en) | Skincare compositions | |
| AU352808S (en) | Dispenser for curable compositions | |
| IL245420B (en) | New formulations | |
| GB201305556D0 (en) | Skincare compositions | |
| ZA201505738B (en) | Ganglioside compositions | |
| ZA201505650B (en) | New compositions | |
| GB201320962D0 (en) | Compositions | |
| SG11201600573VA (en) | Curable compositions | |
| GB201316463D0 (en) | Novel compositions | |
| SG11201509114TA (en) | Pharmaceutical compositions | |
| GB201320959D0 (en) | Compositions | |
| PT3041488T (pt) | Composições de mel | |
| GB201304699D0 (en) | Pharmaceutical compositions | |
| GB201312224D0 (en) | Compositions |